Last edition
News about Market
Virupaksha Organics Files Draft Papers with SEBI for INR 740 Crore IPO
Virupaksha Organics, an R&D-driven Indian pharmaceutical company specialising in active pharmaceutical ingredients (APIs) and intermediates, has filed draft papers with India’s capital markets regulator, SEBI, to raise INR 740 crore through an initial public offering (IPO).
Market | 01/10/2025 | By Darshana | 284
Testo Saveris to Showcase Comprehensive Pharma Monitoring System at CPHI 2025
Instrumentation and measurement specialist Testo Saveris will present its fully automated and comprehensive monitoring system, testo Saveris 1 at CPHI 2025 in Frankfurt, taking place from 28–30 October.
Market | 01/10/2025 | By Dineshwori | 225
India's Pharma Exports Set to Cross USD 30 Billion by Year-End: Dr Jitendra Singh
India’s pharma exports, currently valued at nearly USD 27.8 billion, are expected to cross USD 30 billion by the end of this year, Union Minister Dr. Jitendra Singh said.
Market | 01/10/2025 | By Dineshwori | 318
Novo Nordisk to Launch Ozempic in India
The once-a-week injectable, Ozempic will complement Novo Nordisk’s existing oral Semaglutide for diabetes and recently approved WeGovy for obesity.
Market | 30/09/2025 | By Dineshwori | 575
GlobalData's AI Tool Predicts Pharmaceutical Drug Approvals with 85 Percent Success Rate
GlobalData’s enhanced AI-powered Likelihood of Approval (LoA) model boosts its predictive power, providing probability of a drug receiving market authorisation.
Market | 29/09/2025 | By Dineshwori | 403
Trump's 100 Percent Pharma Tariff to Have Twofold Impact on Indian Drugmakers
The proposed tariffs target only branded and patented medicines, leaving India’s generic exports largely unaffected. While companies making branded drugs for the US may face challenges, domestic generic producers could benefit from increased demand for affordable alternatives.
Market | 29/09/2025 | By Dineshwori | 585
Anbenitamab Set to Lead as First Bispecific mAb in China's HER2+ Gastric Cancer Market: GlobalData
China’s NMPA has accepted Alphamab Oncology’s NDA for KN026 (Anbenitamab), which could become the first bispecific mAb for HER2-positive gastric and GEJ cancer, according to GlobalData.
Market | 25/09/2025 | By Dineshwori | 450
Vidal Health and SII Collaborate on HPV Vaccine Access
Vidal Health and Serum Institute of India (SII) have partnered to boost cervical cancer prevention, launching from 1 October 2025 a first-of-its-kind cashless platform for HPV vaccination—covering digital bookings, consent, and certification with zero paperwork.
Market | 24/09/2025 | By Dineshwori | 240
Asia Pacific Leads Global Pharmaceutical Capsule Filling Machines Market
The Asia Pacific region dominated the global pharmaceutical capsule filling machines market in 2024, capturing a 40 percent share, according to a report by Precedence Research.
Market | 23/09/2025 | By Dineshwori | 275
Rubicon Research, a pharmaceutical formulations company, has announced that in a pre-IPO transaction, General Atlantic Singapore RR transferred 2.889 million equity shares to TIMF Holdings and 360 ONE funds at INR 484.47 per share, aggregating to INR 140 crore.
Market | 22/09/2025 | By Darshana | 837
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy